Covid19

Intranasal delivery of AstraZeneca COVID-19 vaccine fails to generate strong immune response

CanSinoBio's 'Convidecia Air' Recombinant COVID-19 vaccine (adenovirus Type 5 vector) for inhalation was approved in China in September as a …

Read more at www.biopharma-reporter.com

Show More

Related Articles

Back to top button